Wilson disease as a cause of liver injury in cystic fibrosis
Language English Country Netherlands Media print-electronic
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
18948065
DOI
10.1016/j.jcf.2008.09.003
PII: S1569-1993(08)00140-9
Knihovny.cz E-resources
- MeSH
- Chelating Agents therapeutic use MeSH
- Cystic Fibrosis complications diagnosis MeSH
- Diagnosis, Differential MeSH
- Child MeSH
- Genetic Testing MeSH
- Genotype MeSH
- Gilbert Disease diagnosis genetics MeSH
- Hepatolenticular Degeneration diagnosis drug therapy genetics MeSH
- Liver Function Tests MeSH
- Liver pathology MeSH
- Humans MeSH
- Mutation MeSH
- Infant, Premature MeSH
- Infant, Newborn MeSH
- Penicillamine therapeutic use MeSH
- Child, Preschool MeSH
- Pyridoxine therapeutic use MeSH
- Vitamin B Complex therapeutic use MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Chelating Agents MeSH
- Penicillamine MeSH
- Pyridoxine MeSH
- Vitamin B Complex MeSH
Cystic fibrosis-related liver disease affects approximately one third of all patients with cystic fibrosis. Initial signs of other liver diseases including the genetically determined disorders of the liver co-inherited with cystic fibrosis may be obscured by or ascribed to cystic fibrosis-related liver disease. We report a patient shown to suffer simultaneously from cystic fibrosis and hepatic Wilson disease. Our case documents that in patients with cystic fibrosis presenting with liver disease, when unusual clinical and/or laboratory abnormalities appear and fail to respond to standard therapy, a second disease, including rare inherited metabolic disorders such as the hepatic form of Wilson disease or alpha(1)-antitrypsin deficiency, should be suspected.
References provided by Crossref.org